Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorder
Objective Serum AQP4 antibody (AQP4-IgG) is the causative antibody of neuromyelitis optica spectrum disorder (NMOSD) but AQP4-IgG in cerebrospinal fluid (CSF) has been seldom studied. We aimed to explore the clinical value and influencing factors of CSF AQP4-IgG in NMOSD. Methods In this study, we screened 137 patients with NMOSD diagnosed according to the 2015 International Consensus Diagnostic Criteria (IPND criteria). From this cohort, paired CSF and serum samples were simultaneously collected from 82 patients (including seropositive and seronegative subgroups) for antibody titer measurement. We explored the relationship between CSF AQP4-IgG and patient's clinical features. Their demographic, clinical, laboratory data and MRI images were collected and analyzed. Results 74 patients were seropositive for AQP4-IgG and 8 patients were seronegative. Among the 74 patients seropositive for AQP4-IgG, 46 were CSF-positive and 28 were CSF-negative, while none of the 8 seronegative patients were CSF-positive. CSF AQP4-IgG positive and negative patients showed significant differences in EDSS and relapse status. Out of the 82 patients, 67 patients were during relapse and only patients during relapse were included in the next analysis. Between the CSF-positive and CSF-negative patients, no significant differences were found in EDSS, relapse manifestation, CSF indicators, serum cytokine levels, lymphocyte subsets or MRI lesions. Responses to treatment during relapse and length of hospital stay showed no significant differences either. A positive correlation between the serum and CSF titers (rs: 0.64, p < 0.001) was found. Further binary logistic regression analysis revealed that CSF AQP4-IgG positivity was associated with serum AQP4-IgG titers and EDSS scores. Conclusions CSF AQP4-IgG positivity primarily results from passive diffusion of serum antibodies across the blood-brain barrier, which is different from the CNS-restricted antibody production in MOG-IgG associated disorders (MOGAD). Limited prognostic value of CSF AQP4-IgG was revealed in this study.
基金:
Shanghai "Rising Stars of Medical Talents" Youth Development Program; Interdisciplinary Program of Shanghai Jiao Tong University [YG2023LC04]; Innovative research team of high-level local universities in Shanghai [SHSMUZ-DCX20211901]; New Quality Clinical Specialties of High-end Medical Disciplinary Construction in Pudong New Area [2024-PWXZ-16]
第一作者机构:[1]Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Neurol, Shanghai 200127, Peoples R China[4]Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurol, Punan Branch,Sch Med, Shanghai 200125, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Peng Jing,Yu Feifei,Zhou Xiajun,et al.Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorder[J].ACTA NEUROLOGICA BELGICA.2025,doi:10.1007/s13760-025-02853-5.
APA:
Peng, Jing,Yu, Feifei,Zhou, Xiajun,Wu, Yifan,Wang, Kan...&Xie, Chong.(2025).Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorder.ACTA NEUROLOGICA BELGICA,,
MLA:
Peng, Jing,et al."Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorder".ACTA NEUROLOGICA BELGICA .(2025)